Immunic Therapeutics’ Post

🧠 Hoping for some more clever minds than mine to help answer this… it relates to innovation in the future: ✂️With all the cuts being within R&D, are we likely to see a big gap in innovation within 2-5 years? Yeah of course things will pick back up, but right now they aren't and despite these younger companies' science being sound they also aren't receiving investment (another topic!) So, will we see a big gap in a few years down the line? 🤔 #lifesciences #biotech #pharma #SJRLifesciences

What is biotechnology and why has it become an increasingly prominent niche within the alternative investments market? Our latest article describes what this new technology consists of and how this market is spearheading innovation within the medical industry. https://lnkd.in/ewVMSe3R Join the conversation! Share your thoughts in the comments and tag someone who would find this article interesting. #Biotech

🔬Developments in Biotech! 🔬 Pfizer is forging ahead in the world of biotech with a groundbreaking partnership with Ginkgo Bioworks. 🤝 This £331 million deal is set to unlock new possibilities in the field, although the specific targets remain undisclosed. Collaborations like these are crucial in advancing innovation and addressing critical health challenges. Together, we can push the boundaries of science and make a positive impact on global health. #Biotech #Innovation #Pfizer #GinkgoBioworks #Science #Healthcare [Link to the article: https://lnkd.in/e-HK5Va6]

📉 #MarketingTrends & Forecasts: #B2Bmarketing firms are spending less and focused on #ROI for #2023 and #2024 ⛔ #Martech spending will be more conservative compared with previous years. Firms are reevaluating and consolidating their tech setups to maximize ROI. Many are “disinvesting” from technologies that fail to provide the desired outcomes. Source: https://buff.ly/3Q5xRIg #lifescience #biotech #biotechnology #pharma #healthcare

Drug discovery successes soared in the past decade fueled by record investment, however, today’s tight and uncertain capital market threatens to slow the pace of innovation. Biotech investment has plummeted since 2021, with investment for the 1H 2023 reminiscent of the Great Recession years. This article explores the historical capital cycle, how it differs from the recent past, and what you can do to navigate today's capital crunch.  #healthcare #venturecapital #privateequity #biotech #biotechnology #innovation #commercialization #capitalmarkets

🔗💡 Uniting for Innovation: Portfolio Synergies in Drug Development 🔗💡 The Drug Development puzzle isn’t only about solving but also about how the pieces come together to create a powerful, transformative whole. Just as diverse elements harmonize to build something greater, the strategic alignment of portfolios holds the key to unlocking synergies that propel innovation and streamline progress. . . . #biotech #venturecapitalists #biotechnology #celltherapy #clinicalresearch #patientcentricity #drugdevsubscription #ubuntu #ubunturesearch

ALGANELLE entreprise celebrates its creation 10 years ago! An opportunity to bring together the teams, partners and supporters that have contributed to this success. After a tour of the labs, Pierre Luzeau, CEO of Seqens, Ghislaine Tissot-Lécuelle, Founder & CEO of Alganelle, and Luc Berthoud, Vice President of the Greater Chambery Area, shared their visions of the future of biotechnologies. 🌿 Since its creation, this leading-edge biotech is convinced that synthetic biology is key to the future of industry. 👉 How? By harnessing the power of nature. Microalgae, used as photosynthetic cell factories, enables the development of efficient, sustainable and safe production of vegan and bio-inspired metabolites, bioactive peptides, and proteins. 👉 For what applications ? Microalgae are used by the cosmetics industry, for biomedical and pharmaceutical products, and the manufactyring of biomaterials. 🤝 A year ago, and after holding a minority stake since 2016, SEQENS became Alganelle's majority shareholder, sealing a common ambition to develop innovative and sustainable production routes on high value ingredients. #biotech #pharmaceuticals #development #cosmetics #sustainable

The biotech industry continues to grow and scale up, and biomanufacturing has become an increasingly important aspect of the field. As so many components are involved in producing biopharmaceuticals, microbial, cell-based or mRNA products, knowing where to start and with whom to partner is crucial. There are many things to keep in mind: 👉 staying up-to-date on the latest industry trends and advancements, 👉 ensuring the quality of the products, 👉 understanding of the regulatory landscape surrounding biomanufacturing, etc. Our panel will delve into a range of crucial topics that biotech companies inevitably encounter in their operations. Join us during #CEBioForum2024 conference: "How to handle biomanufacturing?" ❇️ Dr Adriana Kiędzierska - Mencfeld - Polpharma Biologics ❇️ Lukasz Paciorkowski - A4BEE ❇️ Dominik Lipka PhD Eng. - SyVento BioTech ❇️ Monika Kozdron-Sikorska - ExecMind. Life Science Executive Search #CEBioForum2024 #biomanufacturing #bioproduction

The Back Bay 2023 Year in review is below and I expect the 2024 year in review will look markedly different. We will see continued biopharma and biotechnology advance, markets appear to be clearly reinvigorating though there are likely some turbulent moments ahead, and I truly believe we will see a logical and compelling impact of health technology and medtech growth as issues regarding care delivery continue to refine. DNB//Back Bay will be there in the thick of it and we are excited for the events ahead. https://lnkd.in/e6QzrK3u

What can pharma industry expect for 2024? Here are some interesting key takeaways from the JPM conference that often lay the groundwork for future developments throughout the year. M&A activities are continuing to raise especially in the vaccine area. Precision medicine and implementation of AI will further foster growth within the pharma industry leading to a positive mindset within the industry. #pharmaindustry #biotech #2024 #innovation #growth